Last reviewed · How we verify

NCT04603118

Optic Nerve Sheath Diameters in Idiopathic Intracranial Hypertension Patients

Completed NA Last updated 26 October 2020
What this trial tests

NA trial testing Optic ultrasonography in Pseudotumor Cerebri in 47 participants. Completed in 1 April 2016.

Timeline
1 May 2014
Primary endpoint
31 December 2015
1 April 2016

Quick facts

Lead sponsorEge University
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationnon randomized
Designparallel
Maskingnone
Primary purposediagnostic
Enrollment47
Start date1 May 2014
Primary completion31 December 2015
Estimated completion1 April 2016
Sites1 location across Turkey (Türkiye)

Drugs / interventions tested

Conditions studied

Sponsor

Ege University

Who can join

Adults 17 to 65, any sex, with Pseudotumor Cerebri. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Idiopathic intracranial hypertensionis a type of increased intracranial pressure. Diagnosis is made by lumbar puncture, which is an invasive technique. The relationship between ICP and optic nerve sheath diameters (ONSD) were examined in our study. Thus, it was investigated whether the optic nerve sheath diameter could be used in the diagnosis of IIH. In the present study, it was found that ONSD measurement by optic USG significantly reflects increased ICP and decreasing pressure via LP is rapidly reflects to ONSD measurement. And it is suggested that ONSD measurements by optic USG, a non-invasive method, can be used in the diagnosis and follow-up of IIH patients.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Pseudotumor Cerebri

Currently open trials in the same condition.

Other Ege University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04603118.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing